Citations 1
Safety and tolerability of the bolus 5-fluorouracil (5-FU) based FLOX and IFL regimens in patients who developed fluoropyrimidine-induced coronary vasospasm during therapy with infusional 5-FU or capecitabine.
Chakrabarti, Sakti , Sara, Jaskanwal Deep Singh , Lobo, Ronstan , Finnes, Heidi D. , Mitchelll, Jessica L, Hartgers, Mindy L., Okano, Akiko, Hálfdánarson, Þorvarður R. , Grothey, Axel, Halfdanarson, Thorvardur R , Chakrabarti, Sakti , Eiring, Rachel A. , Okano, Akiko
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e15513-e15513
